| Advice You |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Productivity > The Vital Few Give Success to You |
|
Advice You - The Vital Few Give Success to You
Richard Koch, in his book. The 80/20 Principle, he describes the Principle as comprising of radar and autopilot. The radar for insight a According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product nd the autopilot for control. In other words to easily think 80/20 and act 80/20 in all that we do. Vital Few Even if ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in we accept the idea, it is hard to take the next step and take action. Continually think about the vital few and spend more time and eff lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ort with them and avoid the majority. A few people add most of the value The best people who are matched to the right here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ob are the most productive and generate enormous surpluses, far more than what they make personally. These are usually only a very few w d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ith the majority generating little more than they make personally. This problem is greater in larger and more diversified companies. Th ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ere are many reasons for this: hard to measure performance political skill tendencies to favor remaining equal The entrepreneur with easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi four employees knows who is making the organization money and how much without a P&L department. Where a large company depends on misle nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ding accounting data and filter provided by the head of human resources. Misallocation of resources We continue to giv and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ e resources to activities with low margins and few resources to activities with high margins. We should redirect the majority of resourc ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi es to the activities with the highest profit margins. Success is undervalued Success is too often thought of as a luck ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a y break. There is always something behind that lucky break even if we fail to recognize it.
Look for small causes, small products, sma dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod l firms, small markets, small systems, as all of these are often the start of something big. Our attention is usually on what already ex cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ists not on the trend shown in small things. Stop thinking 50/50 Think skewness. Expect 20 percent to equal 80 percen tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen t. Expect the unexpected. Expect your 20 percent to lead to 80 percent. Expect everything. Time, your company, your market, everythin t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel g to a powerful 20 percent waiting to do more. Expect tomorrow's 20 percent to be different. Block from your view the existing 80 perce ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust t and free up your vision for the elusive 20 percent. This is where the fortunes are made. The best way to start thinking 80/20 is to s y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products tart acting 80/20 and the best way to start acting 80/20 is to start thinking 80/20. Jesus spoke in parables to the masses and showed th . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de em miracles, but he spent time with the few and taught them the meaning of the parables and the power to work miracles. Jesus knew the v elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip alue of the 80/20 principle and the results it would produce. Suggested reading: The 80/20 Principle, By Richard Koch, ISBN 0-385-49174- tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:The Importance of Background Checks What To Do With Your Business Cards Decision Support System : A Snap Shot
|